Please login to the form below

Not currently logged in
Email:
Password:

Ferring appoints executive VP and chief medical officer

Professor Klaus Dugi joins the pharma group from Boehringer Ingelheim

Klaus DugiFerring Pharmaceuticals has appointed professor Klaus Dugi as its executive vice president and chief medical officer; roles that will see him take the helm of its global medical affairs, quality assurance and pharmacovigilance business.

Prior to his new role, Professor Dugi has held various leadership roles at Boehringer Ingelheim, including vice president, global affairs, chief medical officer, and most recently managing director UK and Ireland.

Michel Pettigrew, president of the executive board and chief operating officer, Ferring Pharmaceuticals, said: “Making the industry more patient-centric has always been a top priory for Professor Dugi, and this is perfectly aligned with our company philosophy and commitment so solving unmet patient needs, particularly in the area of reproductive and maternal health.”

Additionally, Professor Dugi will also be a member of the Swiss group’s medical board, effective immediately.

12th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
So how do you really engage with patients?
The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...
data
Avoiding data pitfalls in clinical research
Genomics sequencing and sensors will present new challenges...

Infographics